CANNASSURE THERAPE financial statements, including revenue, expenses, profit, and loss
The total revenue of CSURE-M for the last semiannual is 462.00 k ILS, and it's 95.62% lower compared to the previous semiannual. The net income of H2 23 is -1.23 M ILS.